These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
273 related articles for article (PubMed ID: 16401470)
1. Prevalence of early onset colorectal cancer in 397 patients with classic Li-Fraumeni syndrome. Wong P; Verselis SJ; Garber JE; Schneider K; DiGianni L; Stockwell DH; Li FP; Syngal S Gastroenterology; 2006 Jan; 130(1):73-9. PubMed ID: 16401470 [TBL] [Abstract][Full Text] [Related]
2. Germline TP53 Mutations in Patients With Early-Onset Colorectal Cancer in the Colon Cancer Family Registry. Yurgelun MB; Masciari S; Joshi VA; Mercado RC; Lindor NM; Gallinger S; Hopper JL; Jenkins MA; Buchanan DD; Newcomb PA; Potter JD; Haile RW; Kucherlapati R; Syngal S; JAMA Oncol; 2015 May; 1(2):214-21. PubMed ID: 26086041 [TBL] [Abstract][Full Text] [Related]
3. TP53 germline mutation testing in 180 families suspected of Li-Fraumeni syndrome: mutation detection rate and relative frequency of cancers in different familial phenotypes. Ruijs MW; Verhoef S; Rookus MA; Pruntel R; van der Hout AH; Hogervorst FB; Kluijt I; Sijmons RH; Aalfs CM; Wagner A; Ausems MG; Hoogerbrugge N; van Asperen CJ; Gomez Garcia EB; Meijers-Heijboer H; Ten Kate LP; Menko FH; van 't Veer LJ J Med Genet; 2010 Jun; 47(6):421-8. PubMed ID: 20522432 [TBL] [Abstract][Full Text] [Related]
4. Beyond Li Fraumeni Syndrome: clinical characteristics of families with p53 germline mutations. Gonzalez KD; Noltner KA; Buzin CH; Gu D; Wen-Fong CY; Nguyen VQ; Han JH; Lowstuter K; Longmate J; Sommer SS; Weitzel JN J Clin Oncol; 2009 Mar; 27(8):1250-6. PubMed ID: 19204208 [TBL] [Abstract][Full Text] [Related]
5. Li-Fraumeni and Li-Fraumeni-like syndrome among children diagnosed with pediatric cancer in Southern Brazil. Giacomazzi J; Selistre SG; Rossi C; Alemar B; Santos-Silva P; Pereira FS; Netto CB; Cossio SL; Roth DE; Brunetto AL; Zagonel-Oliveira M; Martel-Planche G; Goldim JR; Hainaut P; Camey SA; Ashton-Prolla P Cancer; 2013 Dec; 119(24):4341-9. PubMed ID: 24122735 [TBL] [Abstract][Full Text] [Related]
6. Prevalence and diversity of constitutional mutations in the p53 gene among 21 Li-Fraumeni families. Birch JM; Hartley AL; Tricker KJ; Prosser J; Condie A; Kelsey AM; Harris M; Jones PH; Binchy A; Crowther D Cancer Res; 1994 Mar; 54(5):1298-304. PubMed ID: 8118819 [TBL] [Abstract][Full Text] [Related]
7. Prevalence of germline TP53 mutations and history of Li-Fraumeni syndrome in families with childhood adrenocortical tumors, choroid plexus tumors, and rhabdomyosarcoma: a population-based survey. Magnusson S; Gisselsson D; Wiebe T; Kristoffersson U; Borg Å; Olsson H Pediatr Blood Cancer; 2012 Nov; 59(5):846-53. PubMed ID: 22653678 [TBL] [Abstract][Full Text] [Related]
8. Molecular basis of the Li-Fraumeni syndrome: an update from the French LFS families. Bougeard G; Sesboüé R; Baert-Desurmont S; Vasseur S; Martin C; Tinat J; Brugières L; Chompret A; de Paillerets BB; Stoppa-Lyonnet D; Bonaïti-Pellié C; Frébourg T; J Med Genet; 2008 Aug; 45(8):535-8. PubMed ID: 18511570 [TBL] [Abstract][Full Text] [Related]
9. The TP53 gene promoter is not methylated in families suggestive of Li-Fraumeni syndrome with no germline TP53 mutations. Finkova A; Vazna A; Hrachovina O; Bendova S; Prochazkova K; Sedlacek Z Cancer Genet Cytogenet; 2009 Aug; 193(1):63-6. PubMed ID: 19602465 [TBL] [Abstract][Full Text] [Related]
11. Li-Fraumeni and related syndromes: correlation between tumor type, family structure, and TP53 genotype. Olivier M; Goldgar DE; Sodha N; Ohgaki H; Kleihues P; Hainaut P; Eeles RA Cancer Res; 2003 Oct; 63(20):6643-50. PubMed ID: 14583457 [TBL] [Abstract][Full Text] [Related]
12. TP53 germline mutation may affect response to anticancer treatments: analysis of an intensively treated Li-Fraumeni family. Kappel S; Janschek E; Wolf B; Rudas M; Teleky B; Jakesz R; Kandioler D Breast Cancer Res Treat; 2015 Jun; 151(3):671-8. PubMed ID: 25981898 [TBL] [Abstract][Full Text] [Related]
13. [Germline mutations of the p53 gene]. Frebourg T Pathol Biol (Paris); 1997 Dec; 45(10):845-51. PubMed ID: 9769948 [TBL] [Abstract][Full Text] [Related]
14. The profile and contribution of rare germline copy number variants to cancer risk in Li-Fraumeni patients negative for TP53 mutations. Silva AG; Krepischi AC; Pearson PL; Hainaut P; Rosenberg C; Achatz MI Orphanet J Rare Dis; 2014 Apr; 9():63. PubMed ID: 24775443 [TBL] [Abstract][Full Text] [Related]
15. Pediatric cancer and Li-Fraumeni/Li-Fraumeni-like syndromes: a review for the pediatrician. Giacomazzi CR; Giacomazzi J; Netto CB; Santos-Silva P; Selistre SG; Maia AL; Oliveira VZ; Camey SA; Goldim JR; Ashton-Prolla P Rev Assoc Med Bras (1992); 2015; 61(3):282-9. PubMed ID: 26248253 [TBL] [Abstract][Full Text] [Related]
16. Germ-line mutations of TP53 in Li-Fraumeni families: an extended study of 39 families. Varley JM; McGown G; Thorncroft M; Santibanez-Koref MF; Kelsey AM; Tricker KJ; Evans DG; Birch JM Cancer Res; 1997 Aug; 57(15):3245-52. PubMed ID: 9242456 [TBL] [Abstract][Full Text] [Related]
17. p53 Germline mutation in a patient with Li-Fraumeni Syndrome and three metachronous malignancies. Pötzsch C; Voigtländer T; Lübbert M J Cancer Res Clin Oncol; 2002 Aug; 128(8):456-60. PubMed ID: 12200603 [TBL] [Abstract][Full Text] [Related]